OncoNeuroX Therapeutics is pioneering a revolutionary approach to treating some of the most challenging diseases facing humanity. By recognizing and harnessing the shared biological pathways between cancer and neurodegenerative diseases, we are developing novel therapies that address the root causes of aging-related conditions. Our mission is to transform our understanding of cellular senescence and lysosomal dysfunction into disease-modifying treatments that can extend healthy lifespan and improve quality of life for patients worldwide.

Our innovative platform focuses on conditions including Alzheimer’s disease, Lewy Body dementia, frontotemporal dementia (FTD), and various cancers. By leveraging insights from cancer biology and applying them to neurodegeneration, we are uncovering therapeutic opportunities that were previously overlooked. Our commitment to scientific excellence and patient-centric innovation positions us at the forefront of the biotechnology industry, dedicated to delivering transformative treatments that address unmet medical needs.